Gilead Sciences Inc. (GILD)

Index:

Nasdaq 100

$ 170.68
   
  • Change Today:
    $5.07
  • 52 Week High: $175.65
  • 52 Week Low: $118.15
  • Currency: US Dollars
  • Shares Issued: 1,241.00m
  • Volume: 11,427,256
  • Market Cap: $211,814m
  • RiskGrade: 120
  • Beta: 0.01

Latest ShareCast News

Gilead Sciences to buy German biotech group Tubulis for up to $5bn

By Michele Maatouk

Date: Tuesday 07 Apr 2026

(Sharecast News) - California-based Gilead Sciences said on Tuesday that it has agreed to buy German clinical stage biotechnology group Tubulis for up to $5bn.

Gilead Sciences to snap up Arcellx in near $8bn deal

By Abigail Townsend

Date: Monday 23 Feb 2026

(Sharecast News) - Shares in Arcellx soared on Monday, after the US biotech agreed to be taken over by Gilead Sciences in a near $8bn deal.

GSK's ViiV says trial indicates HIV shot as effective as rival Gilead pill

By Frank Prenesti

Date: Thursday 23 Feb 2023

(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.

Gilead raises 2020 forecasts after Covid-19 surg... 11-Jan-2021 ShareCast
FDA grants EUA for Eli Lilly treatment in conjun... 20-Nov-2020 ShareCast
WHO advises against prescribing remdesivir for C... 20-Nov-2020 ShareCast
Eli Lilly halts late stage trial into Covid-19 a... 27-Oct-2020 ShareCast
FDA grants full approval to Gilead Sciences's Ve... 23-Oct-2020 ShareCast
Gilead Sciences's Remdesivir may cut Covid-19 ri... 10-Jul-2020 ShareCast
Single course of Covid-19 treatment to cost $2,3... 29-Jun-2020 ShareCast
Gilead Sciences to test inhaled version of Covid... 22-Jun-2020 ShareCast
JP Morgan stays at overweight on AstraZeneca fol... 08-Jun-2020 ShareCast
AstraZeneca approached Gilead about merger - rep... 08-Jun-2020 ShareCast
Sunday newspaper round-up: Pandemic, Jobs, Astra... 07-Jun-2020 ShareCast
Japan approves Gilead Sciences's Remdesivir for ... 07-May-2020 ShareCast
Top US expert hails 'quite good news' on Gilead ... 29-Apr-2020 ShareCast
Gilead Sciences shares halted after 'positive da... 29-Apr-2020 ShareCast
RBC Capital labels news on Gilead Science's Remd... 17-Apr-2020 ShareCast
Europe midday: Stocks snap back amid optimism fo... 17-Apr-2020 ShareCast
Gilead treatment has positive results on Covid-1... 17-Apr-2020 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GILD Market Data

Currency US Dollars
Share Price $ 170.68
Change Today $ 5.07
% Change 3.06 %
52 Week High $175.65
52 Week Low $118.15
Volume 11,427,256
Shares Issued 1,241.00m
Market Cap $211,814m
Beta 0.01
RiskGrade 120

What The Brokers Say

Strong Buy 8
Buy 15
Neutral 5
Sell 1
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 30-Oct-2026

Time Volume / Share Price
15:59 1,085 @ $170.80
15:59 800 @ $170.80
15:59 100 @ $170.80
15:59 300 @ $170.80
15:59 2,415 @ $170.80

Top of Page